000143310 001__ 143310
000143310 005__ 20240229112547.0
000143310 0247_ $$2doi$$a10.1002/pbc.27625
000143310 0247_ $$2pmid$$apmid:30693642
000143310 0247_ $$2ISSN$$a0098-1532
000143310 0247_ $$2ISSN$$a1096-911X
000143310 0247_ $$2ISSN$$a1545-5009
000143310 0247_ $$2ISSN$$a1545-5017
000143310 037__ $$aDKFZ-2019-00900
000143310 041__ $$aeng
000143310 082__ $$a610
000143310 1001_ $$00000-0001-9791-0104$$aEl-Ayadi, Moatasem$$b0
000143310 245__ $$aOccurrence of high-grade glioma in Noonan syndrome: Report of two cases.
000143310 260__ $$aNew York, NY$$bWiley$$c2019
000143310 3367_ $$2DRIVER$$aarticle
000143310 3367_ $$2DataCite$$aOutput Types/Journal article
000143310 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1573808289_8873
000143310 3367_ $$2BibTeX$$aARTICLE
000143310 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143310 3367_ $$00$$2EndNote$$aJournal Article
000143310 520__ $$aNoonan syndrome (NS) is an autosomal dominant disorder commonly caused by PTPN11 germline mutations. Patients are characterized by short stature, congenital heart defects, facial dysmorphism, and increased risk of malignancies including brain tumors. Commonly associated brain tumors are dysembryoplastic neuroepithelial tumor and low-grade glioma. We report two cases of anaplastic astrocytoma with PTPN11-related NS. We conducted a systematic search of medical databases looking for other reported cases of high-grade glioma associated with NS and identified 24 cases of brain tumors, all of which were low-grade glial or glioneuronal tumors except for one case of medulloblastoma.
000143310 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000143310 588__ $$aDataset connected to CrossRef, PubMed,
000143310 7001_ $$aAnsari, Marc$$b1
000143310 7001_ $$aKühnöl, Caspar D$$b2
000143310 7001_ $$00000-0002-2062-0974$$aBendel, Anne$$b3
000143310 7001_ $$0P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807$$aSturm, Dominik$$b4$$udkfz
000143310 7001_ $$aPietsch, Torsten$$b5
000143310 7001_ $$aKramm, Christof M$$b6
000143310 7001_ $$00000-0003-4197-6264$$avon Bueren, André O$$b7
000143310 773__ $$0PERI:(DE-600)2130978-4$$a10.1002/pbc.27625$$gVol. 66, no. 5, p. e27625 -$$n5$$pe27625$$tPediatric blood & cancer$$v66$$x1545-5017$$y2019
000143310 909CO $$ooai:inrepo02.dkfz.de:143310$$pVDB
000143310 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000143310 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000143310 9141_ $$y2019
000143310 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143310 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143310 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143310 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPEDIATR BLOOD CANCER : 2017
000143310 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143310 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143310 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143310 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143310 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000143310 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143310 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000143310 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x0
000143310 980__ $$ajournal
000143310 980__ $$aVDB
000143310 980__ $$aI:(DE-He78)B062-20160331
000143310 980__ $$aUNRESTRICTED